BOLD Stock Analysis: Buy, Sell, or Hold?
BOLD - Boundless Bio, Inc. Common Stock
$2.50
0.02 (0.81%)
▲
5d:
-0.4%
30d:
+74.83%
90d:
+121.24%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When BOLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BOLD is 16.3% above its trading range ($2.15). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BOLD is 16.3% above its trading range ($2.15). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BOLD is currently trading at $2.50, which is considered extended relative to its 30-day fair value range of $1.21 to $2.15.
Technical Outlook: Technically, BOLD is in a strong uptrend. Immediate support is located at $1.40, while resistance sits at $2.79.
Market Sentiment: BOLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+60.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BOLD is in a strong uptrend. Immediate support is located at $1.40, while resistance sits at $2.79.
Market Sentiment: BOLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.00 (+60.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.21 -
$2.15
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+16.3% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 60.0% below Wall St target ($4.00)
- WARNING: Recommendation downgraded due to 16.3% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.21 -
$2.15
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$2.79
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.69
Wall Street Target
$4.00
(+60.0%)
Share & Embed Analysis
Last updated: July 02, 2026 10:34 PM ET
Data refreshes hourly during market hours. Next update: 11:34 PM
Data refreshes hourly during market hours. Next update: 11:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BOLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 64 BUY |
